Share

Ebola

Latest News

4 Ways Johnson & Johnson Has Worked to Make Access to Medicines Around the World More Equitable

4 Ways Johnson & Johnson Has Worked to Make Access to Medicines Around the World More Equitable

The Access to Medicine Index, a ranking of pharmaceutical companies' work to distribute medications to low- and middle-income countries, just named Johnson & Johnson #3 on its biennial list, underscoring the company's deep history of ensuring people in underserved communities receive the treatments they need.

Innovation

"My 2021 Healthcare Resolution": 7 Johnson & Johnson Leaders Share Their Goals for Advancing Healthcare and Health Equity

"My 2021 Healthcare Resolution": 7 Johnson & Johnson Leaders Share Their Goals for Advancing Healthcare and Health Equity

A potential COVID-19 vaccine. Passionate efforts toward achieving racial and social justice. Smarter, more sustainable product packaging. These are just a few of the resolutions company change makers are aiming to bring to light this year—and they're already hard at work on them.

Innovation

COVID-19 Update: Your Latest Questions About Johnson & Johnson's Investigational Vaccine Candidate Answered

COVID-19 Update: Your Latest Questions About Johnson & Johnson's Investigational Vaccine Candidate Answered

With its Phase 3 clinical trial now fully enrolled, the Global Head of Research & Development at Janssen brings us up to speed on the progress of the company's vaccine candidate, including upcoming key milestones.

Latest News

The Impact of COVID-19 on a Company: 6 Questions for the Chief Financial Officer of Johnson & Johnson

The Impact of COVID-19 on a Company: 6 Questions for the Chief Financial Officer of Johnson & Johnson

When you're the CFO of a company, you have a holistic view of how a pandemic can touch every aspect of a business, especially when it's a healthcare company. So we posed inquiring mind questions to Joe Wolk about what the past eight months have been like for him at the financial helm of the company—via a Zoom interview.

Our Heritage

4 Innovative Ways Johnson & Johnson Has Helped Protect the Public's Health During Outbreaks Since the Late 1800s

4 Innovative Ways Johnson & Johnson Has Helped Protect the Public's Health During Outbreaks Since the Late 1800s

From epidemic masks that the company introduced during the Spanish flu pandemic to work it's doing today on an investigational COVID-19 vaccine, learn how the company has been at the forefront of safeguarding global public health for well over a century.

Latest News

Johnson & Johnson Named to Fast Company's 2020 Best Workplaces for Innovators List

Johnson & Johnson Named to Fast Company's 2020 Best Workplaces for Innovators List

The company is proud to have made the list for the second year in a row. From its work on an Ebola vaccine—and an investigational COVID-19 vaccine—to collaboration taking place across its Johnson & Johnson Innovation centers, we take a look at the innovative spirit that permeates the company's culture.

Latest News

5 Latest Facts About Johnson & Johnson’s Investigational Janssen COVID-19 Vaccine Candidate

5 Latest Facts About Johnson & Johnson’s Investigational Janssen COVID-19 Vaccine Candidate

With its global Phase 3 clinical trial now fully enrolled with approximately 45,000 adult participants, we share the most up-to-date information about the single-dose investigational vaccine candidate.

A potential COVID-19 vaccine

Latest News

Johnson & Johnson and Its Partners Mark a Milestone in the Quest for a Global Preventive HIV Vaccine With the Imbokodo Study

Johnson & Johnson and Its Partners Mark a Milestone in the Quest for a Global Preventive HIV Vaccine With the Imbokodo Study

The clinical trial has completed full immunizations of the company's investigational HIV vaccine regimen. Learn what this means for the future of fighting the disease—and also for the creation of a potential vaccine for COVID-19.

Latest News

5 Latest Facts About Johnson & Johnson's Ebola Vaccine

5 Latest Facts About Johnson & Johnson's Ebola Vaccine

As the European Commission grants Marketing Authorization for the company's Ebola vaccine regimen—a key step towards enabling broader access to it for the people who need it most—we share top facts about the vaccine for the deadly virus.

Innovation

She's a Scientist with One of the World's Most Important Jobs: Creating a Potential COVID-19 Vaccine

She's a Scientist with One of the World's Most Important Jobs: Creating a Potential COVID-19 Vaccine

Imagine being a researcher who is staring down not only a highly infectious virus, but one that's caused the first global pandemic in more than 100 years. Meet Johnson & Johnson's Hanneke Schuitemaker, Ph.D.

Hanneke Schuitemaker, Ph.D., Global Head of Viral Vaccine Discovery and Translational Medicine and the Disease Area Stronghold Leader for Viral Vaccines at Janssen Vaccines & Prevention, a Janssen Pharmaceutical Company of Johnson & Johnson

Innovation

“I’m a Scientist Working on a Potential COVID-19 Vaccine”: Meet a Researcher Who's Studying a Promising Candidate

“I’m a Scientist Working on a Potential COVID-19 Vaccine”: Meet a Researcher Who's Studying a Promising Candidate

Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.

A close-up view of a microscope and a hand

Latest News

What You Need to Know About the Coronavirus—and a Potential Preventive Vaccine

What You Need to Know About the Coronavirus—and a Potential Preventive Vaccine

The coronavirus has made headlines as it has spread from China to other parts of the world. To help stop the global outbreak in its tracks, Johnson & Johnson is already hard at work on a potential preventive vaccine.

Latest News

Johnson & Johnson Named a 2020 Fortune World’s Most Admired Company

Johnson & Johnson Named a 2020 Fortune World’s Most Admired Company

Innovativeness and a commitment to social responsibility are just some of the respected attributes that helped the company land on the prestigious list for another year.

Collage depicting innovations from Johnson & Johnson around Ebola, bladder cancer, HIV and more

Innovation

A Year of Firsts: 6 Ways Johnson & Johnson Made History in 2019

A Year of Firsts: 6 Ways Johnson & Johnson Made History in 2019

From a first-of-its-kind contact lens that darkens when exposed to bright light to the first donation of 500,000 doses of an Ebola vaccine, here are just some of the ways Johnson & Johnson helped change the trajectory of health for humanity this past year.

A Year of Firsts: 6 Ways Johnson & Johnson Made History in 2019

Latest News

Combating Ebola: How a Johnson & Johnson Vaccine Is Helping in the Fight

Combating Ebola: How a Johnson & Johnson Vaccine Is Helping in the Fight

The company has committed to donate up to 500,000 doses of an investigational Janssen vaccine regimen to help protect citizens of the Democratic Republic of the Congo—the site of the world's second largest outbreak of the disease.

Johnson & Johnson Ebola

Load More